KARD — Kardigan, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2123613 ·
Last close
$13.19
Market Cap
$1.23B
52W High
$27.00
52W Low
$12.23
ADV30
527,058
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -86,604,000 | -58,568,000 | 649,251,000 | 78,889,000 | 76,733,000 |
| Jun 2026 | 0 | — | -75,232,000 | -116,236,000 | 721,786,000 | 384,005,000 | 106,264,000 |
| Mar 2026 | 0 | — | -58,710,000 | -56,071,000 | 348,190,000 | 81,548,000 | 648,816,000 |
| Dec 2025 | — | — | — | — | 390,942,000 | 108,989,000 | 641,277,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-160,102,000
Investing CF
$-61,455,000
Financing CF
$537,419,000
CapEx
$-7,502,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.72
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-453,396,000
Inventory
—
Receivables
—
ST Investments
$213,590,000
EBIT TTM
$-217,145,000
Pretax Income TTM
$-251,938,000
Interest Exp TTM
—
Analysts
8
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -201,836,000 | -191,941,000 | 390,942,000 | 641,277,000 | -250,335,000 | -151,056,000 |
| Dec 2024 | 0 | -96,656,000 | -88,658,000 | 63,526,000 | 146,720,000 | -83,194,000 | -18,825,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$721,786,000
Forward EPS
$-4.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SLN | Silence Therapeutics plc | $1.23B | $19.80 | — |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.24B | $29.10 | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $1.23B | $13.14 | — |
| AVLN | Avalyn Pharma Inc. | $1.24B | $27.92 | — |
| NKTR | NEKTAR THERAPEUTICS | $1.23B | $35.91 | — |
News headlines (Yahoo Finance, 1h cache)
Kardigan: Q3 Earnings Snapshot
2026-11-12 12:21 · Yahoo
Kardigan Reports Third Quarter 2026 Financial Results and Recent Business Updates
2026-11-12 12:00 · Yahoo
Kardigan to Participate in the Jefferies Global Healthcare Conference
2026-11-11 12:00 · Yahoo
Kardigan Extends Phase 2 Ataciguat Trial Assessment, Targets 2027 Results
2026-11-07 16:14 · Yahoo
Kardigan Completes Enrollment in Phase 2b KATALYST-AV Trial and Announces New Evidence Supporting Patient Selection and Endpoints for the Evaluation of Ataciguat in Aortic Stenosis
2026-11-06 21:05 · Yahoo
Kardigan Announces Appointment of Kristin Reinke to its Board of Directors
2026-09-30 12:00 · Yahoo
Kardigan to Present at Two September Investor Conferences
2026-09-02 20:05 · Yahoo
3 Top Founder Led Stocks To Watch With Up To 82% Revenue Growth
2026-10-25 03:15 · Yahoo
Kardigan And 2 Founder Run Stocks To Own
2026-10-20 15:15 · Yahoo
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
2026-08-11 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.